During the last three months, 4 analysts shared their evaluations of Adaptimmune Therapeutics ADAP +4.03% Get Free Report , ...

The company reported quarterly earnings of $2.15 per share, which beat the analyst consensus estimate of $2.05. Quarterly ...

HP's fiscal Q4 results beat estimates, but weak Q1 EPS guidance caused stock to fall. Analysts maintain ratings, but revise ...

U.S. dollar falls as inflation rises, tech stocks hit hard, while yen surges on speculation of Bank of Japan rate hike in ...

Rivian CEO RJ Scaringe shared positive comments on Tesla while speaking at the LA Auto Show, calling the Model Y the best EV ...

Since its inception, the Giving Machines have touched the lives of countless individuals. In 2023 alone, over 600,000 people ...

According to Benzinga Pro, D-Wave Quantum's peer group average for short interest as a percentage of float is 6.15%, which ...

Emerson Electric's EMR short percent of float has risen 21.47% since its last report. The company recently reported that it ...

Mitchell DiRaimondo, co-founder of SteelWave, discussed the rise of traditional financial institutions' interest in ...

Vertically integrated cannabis company C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) announced on Tuesday it will ...

Ares Capital has a lower P/E than the aggregate P/E of 46.03 of the Capital Markets industry. Ideally, one might believe that ...

Vasily Shikin, Chief Technology Officer at AppLovin APP, executed a substantial insider sell on November 26, according to an ...